These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 7690219
21. [Pharmacokinetics of oral propafenone in patients with supraventricular arrhythmia]. Buoncuore A, Poirier JM, Jaillon P, Ferry A, Pochmalicki G, Colombel B, Vrancea F, Cheymol G, Valty J. Therapie; 1989; 44(2):79-85. PubMed ID: 2756523 [Abstract] [Full Text] [Related]
22. [Efficacy and tolerance of propafenone in the treatment of cardiac rhythm disorders. Evaluation of a multicenter open trial on 3,687 patients]. Clémenty J, Coste P, Metzinger M. Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):207-12. PubMed ID: 3296928 [Abstract] [Full Text] [Related]
23. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]. Mondillo S, Faglia S, D'Aprile N, Mangiacotti L, Campolo MA, Agricola E, Palazzuoli V. Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496 [Abstract] [Full Text] [Related]
24. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole]. Barnay C, Medvedowsky JL, Clémenty J, Bricaud H, Pellet J, Denis B, Machecourt J, Wolf JE, Dimitrio R, Egre A. Arch Mal Coeur Vaiss; 1983 Aug; 76(8):909-17. PubMed ID: 6194768 [Abstract] [Full Text] [Related]
25. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study. Singh BN, Kaplinsky E, Kirsten E, Guerrero J. Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844 [Abstract] [Full Text] [Related]
26. [Holter analysis of ventricular arrhythmias and its treatment with propafenone]. Peralta Heredia R. Arch Inst Cardiol Mex; 1986 Dec; 56(3):225-30. PubMed ID: 2428317 [Abstract] [Full Text] [Related]
27. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses. Frabetti L, Marchesini B, Capucci A, Cavallini C, Gubelli S, Ambrosioni E, Magnani B. Eur J Clin Pharmacol; 1986 Dec; 30(6):665-71. PubMed ID: 2429844 [Abstract] [Full Text] [Related]
28. [Efficacy and tolerance of propafenone in the prevention after a year of recurrent atrial arrhythmia. Results of a multicenter study of 114 patients]. Sirinelli A, Maarek-Charbit M, Motté G. Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):419-23. PubMed ID: 1285631 [Abstract] [Full Text] [Related]
29. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia. Cai WM, Xu J, Chen B, Zhang FM, Huang YZ, Zhang YD. Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483 [Abstract] [Full Text] [Related]
30. [Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone]. Boriani G, Capucci A, Strocchi E, Marchesini B, Baroni M, Frabetti L, Ambrosioni E, Magnani B. G Ital Cardiol; 1991 May; 21(5):517-26. PubMed ID: 1936756 [Abstract] [Full Text] [Related]
31. [Clinical study of the effectiveness of mexitil in the treatment of patients with extrasystole in old and advanced age]. Korkuschko OW, Butenko AG, Schatilo WB. Z Gerontol; 1987 May; 20(3):149-53. PubMed ID: 2442897 [Abstract] [Full Text] [Related]
32. [Effect of a single oral dose of allapinin in patients with chronic ventricular extrasystole]. Sokolov SF, Alikhanov GN, Golitsyn SP, Koltunova MI, Smetnev AS. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989 May; 12(1):36-42. PubMed ID: 2472819 [Abstract] [Full Text] [Related]
40. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)]. Meyer-Estorf G, Keller K, Beck OA, Hochrein H. Z Kardiol; 1980 Jun; 69(6):417-20. PubMed ID: 6160684 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]